Thyrocare Technologies Ltd share price logo

Thyrocare Technologies Ltd (THYROCARE)

₹646.91.49%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q3 '23 Results
Technicals

Analyst Rating

based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts offering long term price targets for Thyrocare Technologies Ltd. An average target of ₹740

Source: S&P Global Market Intelligence

Thyrocare Technologies Ltd Share analysis

Source: S&P Global Market Intelligence

Performance

  • Day's Low

    Day's High

    ₹634.35
    ₹652
  • 52 Week's Low

    52 Week's High

    ₹506.8
    ₹722.65
1 Month Return-0.62 %
3 Month Return+ 2.37 %
1 Year Return+ 20.31 %
Previous Close₹637.40
Open₹640.00
Volume1.35L
Upper Circuit-
Lower Circuit-
Market Cap₹3,375.20Cr

Key Statistics

P/E Ratio47.5
PEG Ratio128.37
Market Cap₹3,375.20 Cr
P/B Ratio4.53
EPS16.13

Mutual Fund Holdings

Funds HoldingsPrev. 6M
Nippon India Small Cap Fund - Direct Plan - Growth PlanNippon India Small Cap Fund - Direct Plan - Growth Plan0.2%
Nippon India Pharma Fund - Direct Plan - Growth PlanNippon India Pharma Fund - Direct Plan - Growth Plan1.52%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct GrowthICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth1.18%
Quant Small Cap Fund Growth Option Direct PlanQuant Small Cap Fund Growth Option Direct Plan0.2%
ICICI Prudential India Opportunities Fund Direct GrowthICICI Prudential India Opportunities Fund Direct Growth0.23%

Company Information

Thyrocare Technologies Limited was incorporated in 2000 and is one of the leading pan-India diagnostic chains, offering 636 distinct tests and 90 profiles of tests for early detection and management of various disorders and diseases. Additionally, they have set up Regional Processing Laboratories (RPLs) in 25 cities and Thryrocare International Holding Company (TIHC) in Mauritius has established a centre in Bahrain. In 2016, Thyrocare Technologies had a public offering that closed with an oversubscription of 75 times, and in 2018 acquired an Associate Company, Equinox Labs Private Limited, as well as bought back 958900 equity shares. In 2020, their services were negatively affected due to the Coronavirus, however, in 2021 they had a new promoter, Docon Technologies Private Limited, acquire 37656092 equity shares of the Company.As of March 31 2022, Thyrocare Technologies had a network of 1500 active channel partners and more than 9000 collection points spread across 500 districts in India and provided an extensive menu of over 700 tests, with more than 300 added within the year. Additionally, they installed automation for urine testing in 12 lab locations and Beckman Analysers in Zonal Processing Laboratories.

Share Price: ₹646.90 per share as on 11 Jul, 2024 04:01 PM
Market Capitalisation: ₹3,375.20Cr as of today
Revenue: ₹154.25Cr as on March 2024 (Q1 24)
Net Profit: ₹17.18Cr as on March 2024 (Q1 24)
Listing date: 09 May, 2016
Chairperson Name: Rahul Guha
OrganisationThyrocare Technologies Ltd
HeadquartersNavi Mumbai
IndustryHealthcare
E-voting on sharesClick here to vote

Key events for Thyrocare Technologies Ltd

  • Thyrocare Founder Predicts Continued Pressure on Diagnostics Industry - 05 Jul, 2024

    A Velumani, founder of Thyrocare Technologies Ltd, predicts that the diagnostics industry will continue to face pressure for another five years due to COVID-19 disruption. The COVID PCR test led to many players entering the market, but with COVID now under control, infrastructure has gone to waste and too many players are competing, making growth difficult. Consolidation is unlikely due to high acquisition costs and a large number of players.

  • Thyrocare Acquires Polo Labs' Diagnostic Business - 03 Jul, 2024

    Thyrocare Technologies has entered into a Business Transfer Agreement with Polo Labs Private Limited to acquire its diagnostic and pathological services business for Rs 4.26 crore, aiming to expand its own business in the sector.

Insights on Thyrocare Technologies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 15.35 Cr → 17.78 Cr (in ₹), with an average increase of 13.7% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 12.47% to 12.94% in Mar 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 137.6 Cr → 157.74 Cr (in ₹), with an average increase of 12.8% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 71.11% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Max Healthcare Institute Ltd has given 229.6% return, outperforming this stock by 282.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Global Health Ltd has given 78.8% return, outperforming this stock by 58.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, THYROCARE stock has moved down by -53.0%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 11.65% to 11.10% in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 3.35% to 2.90% in Mar 2024 quarter

Company Financials

Value in ₹ crore
Q'1 24Q/Q Change
Revenue
₹154.25Cr
↑14.48%
Net Income
₹17.18Cr
↑16.55%
Net Profit Margin
11.14%
↑1.83%
2023Y/Y Change
Revenue
₹526.67Cr
↓10.56%
Net Income
₹64.36Cr
↓63.46%
Net Profit Margin
12.22%
↓59.14%
Value in ₹ crore
2023Y/Y Change
Total Assets
₹612.62Cr
↑2.50%
Total Liabilities
₹91.58Cr
↑19.01%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
₹120.02Cr
↑13.57%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
71.11%
0.00
Foreign Institutions
2.9%
0.00
Mutual Funds
12.94%
0.00
Retail Investors
11.1%
0.00
Others
1.94%
0.00

Key Indicators

Thyrocare Technologies Ltd Valuation

Thyrocare Technologies Ltd in the last 5 years

  • Overview

  • Trends

Lowest (18.71x)

June 23, 2022

Today (47.50x)

July 10, 2024

Industry (92.34x)

July 10, 2024

Highest (91.79x)

October 27, 2020

LowHigh

Earnings and Dividends

  • Thyrocare Technologies Ltd Earnings Results

    Thyrocare Technologies Ltd’s net profit jumped 41.11% since last year same period to ₹17.78Cr in the Q4 2023-2024. On a quarterly growth basis, Thyrocare Technologies Ltd has generated 15.83% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Thyrocare Technologies Ltd Dividends April,2023

    In the quarter ending March 2023, Thyrocare Technologies Ltd has declared dividend of ₹18 - translating a dividend yield of 5.18%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Thyrocare Technologies Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Thyrocare Technologies Ltd shares.

Thyrocare Technologies Ltd (THYROCARE) share price today is ₹646.9

Thyrocare Technologies Ltd is listed on NSE

Thyrocare Technologies Ltd is listed on BSE

  • Today’s highest price of Thyrocare Technologies Ltd is ₹652.
  • Today’s lowest price of Thyrocare Technologies Ltd is ₹634.35.

PE Ratio of Thyrocare Technologies Ltd is 47.5

PE ratio = Thyrocare Technologies Ltd Market price per share / Thyrocare Technologies Ltd Earnings per share

Today’s traded volume of Thyrocare Technologies Ltd(THYROCARE) is 1.35L.

Today’s market capitalisation of Thyrocare Technologies Ltd(THYROCARE) is ₹3375.2Cr.

Thyrocare Technologies Ltd(THYROCAREPrice
52 Week High
₹722.65
52 Week Low
₹506.8

Thyrocare Technologies Ltd(THYROCARE) share price is ₹646.9. It is down -10.48% from its 52 Week High price of ₹722.65

Thyrocare Technologies Ltd(THYROCARE) share price is ₹646.9. It is up 27.64% from its 52 Week Low price of ₹506.8

Thyrocare Technologies Ltd(THYROCAREReturns
1 Day Returns
9.5%
1 Month Returns
-0.62%
3 Month Returns
2.37%
1 Year Returns
20.31%